Causal survival analysis under competing risks using longitudinal modified treatment policies

From MaRDI portal
Publication:6205052

DOI10.1007/S10985-023-09606-7arXiv2202.03513MaRDI QIDQ6205052FDOQ6205052

Nima S. Hejazi, Katherine L. Hoffman, Iván Díaz

Publication date: 11 April 2024

Published in: Lifetime Data Analysis (Search for Journal in Brave)

Abstract: Longitudinal modified treatment policies (LMTP) have been recently developed as a novel method to define and estimate causal parameters that depend on the natural value of treatment. LMTPs represent an important advancement in causal inference for longitudinal studies as they allow the non-parametric definition and estimation of the joint effect of multiple categorical, numerical, or continuous exposures measured at several time points. We extend the LMTP methodology to problems in which the outcome is a time-to-event variable subject to right-censoring and competing risks. We present identification results and non-parametric locally efficient estimators that use flexible data-adaptive regression techniques to alleviate model misspecification bias, while retaining important asymptotic properties such as sqrtn-consistency. We present an application to the estimation of the effect of the time-to-intubation on acute kidney injury amongst COVID-19 hospitalized patients, where death by other causes is taken to be the competing event.


Full work available at URL: https://arxiv.org/abs/2202.03513







Cites Work


Cited In (1)





This page was built for publication: Causal survival analysis under competing risks using longitudinal modified treatment policies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6205052)